An MSF staff member takes the blood pressure of a 61-year-old patient at the MSF Hepatitis C clinic in Phnom Penh, Cambodia.
CAMBODIA 2017 © Todd Brown
Click to hide Text

This information is excerpted from MSF’s 2016 International Activity Report.

In May 2016, Doctors Without Borders/Médecins Sans Frontières (MSF) launched a hepatitis C program at the Preah Kossamak hospital in Phnom Penh, offering the first free treatment for the virus in Cambodia. By the end of December, 307 patients were on treatment and 183 were on the waiting list. Initial findings indicated that a large percentage of hepatitis C patients were older, and that 50 percent of patients had advanced fibrosis of the liver. Only a small number of HIV patients at the hospital were co-infected with hepatitis C.

MSF’s research project in northern Cambodia was set up to find ways to eliminate malaria in an area where there is proven resistance to the most powerful antimalarial drug, artemisinin. The strategy consists of early diagnosis and treatment for people with symptoms, together with voluntary testing of high-risk groups. In 2016, the project was expanded to test more than 3,000 people who were not showing malaria symptoms. The tests identified 33 people who were carrying the most serious strain of malaria. These patients then received treatment to reduce the chance of transmission. The results will inform health promotion efforts and the next stages of the research project.